Ramipril News and Research

RSS
New study predicts outcomes of CV patients using polypill intervention

New study predicts outcomes of CV patients using polypill intervention

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

New preclinical study shows RG-012 may provide therapeutic benefit for Alport syndrome patients

New preclinical study shows RG-012 may provide therapeutic benefit for Alport syndrome patients

Novel polypill increases patient adherence to treatment following heart attack

Novel polypill increases patient adherence to treatment following heart attack

New polypill increases adherence to treatment following myocardial infarction

New polypill increases adherence to treatment following myocardial infarction

Ramipril puts spring in step of patients with intermittent claudication

Ramipril puts spring in step of patients with intermittent claudication

Ramipril may improve pain-free walking among patients with PAD and intermittent claudication

Ramipril may improve pain-free walking among patients with PAD and intermittent claudication

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

High blood phosphate levels can set CKD patients on a rapid path to kidney failure

High blood phosphate levels can set CKD patients on a rapid path to kidney failure

Ramipril can effectively reduce risk of ESRD in obese patients

Ramipril can effectively reduce risk of ESRD in obese patients

Study: Pycnogenol- offers natural solution for patients with metabolic syndrome

Study: Pycnogenol- offers natural solution for patients with metabolic syndrome

Telmisartan reduces hypertension, cardiovascular risk in ACE-intolerant patients: Boehringer Ingelheim

Telmisartan reduces hypertension, cardiovascular risk in ACE-intolerant patients: Boehringer Ingelheim

Mylan-Nifedipine Extended Release tablets launched in Canada

Mylan-Nifedipine Extended Release tablets launched in Canada

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Pycnogenol counteracts kidney damage due to hypertension

Pycnogenol counteracts kidney damage due to hypertension

Pycnogenol counteracts kidney damage caused by hypertension, improves blood flow to the kidneys

Pycnogenol counteracts kidney damage caused by hypertension, improves blood flow to the kidneys

Watson Pharmaceuticals provides detailed overview of its global operations at Investor Day meeting in NY

Watson Pharmaceuticals provides detailed overview of its global operations at Investor Day meeting in NY

European Commission approves MICARDIS medication for CV protection

European Commission approves MICARDIS medication for CV protection

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke